Low-molecular-weight inhibitors of bacterial DNA-dependent RNA polymerase

Molecular Biology

Volumn 40, Issue 6, 2006, Pages 875-884

  Zorov, S D ^a,b   Yuzenkova, J V ^b   Severinov, K V ^b,c  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b RUTGERS UNIVERSITY   (United States)

^c INSTITUTE OF MOLECULAR GENETICS   (Russian Federation)

Author keywords

CBR703; CBR9379; CBR9393; Daunomycin; Inhibitors of bacterial RNA polymerase; Lipiarmycin; Marcellomycin; Microcin J25; Rifabutin; Rifampicin; Rifamycins; Rifapentin; Sorangicin; Streptolydigin; Tagetitoxin

Indexed keywords

BACTERIA (MICROORGANISMS);

EID: 33845660314     PISSN: 00268933     EISSN: 16083245     Source Type: Journal    
DOI: 10.1134/S0026893306060057     Document Type: Review

References (52)

1. Burgess R.R., Travers A.A. 1970. Escherichia coli RNA polymerase: Purification, subunit structure, and factor requirements. Fed. Proc. 29, 1164-1169.
2. McClure W.R. 1985. Mechanism and control of transcription initiation in prokaryotes. Annu. Rev. Biochem. 54, 171-204.
3. Sosunov V., Sosunova E., Mustaev A., Bass I., Nikiforov V., Goldfarb A. 2003. Unified two-metal mechanism of RNA synthesis and degradation by RNA polymerase. EMBO J. 22, 2234-2244.
4. Dieci G., Hermann-Le Denmat S., Lukhtanov E., Thuriaux P., Werner M., Sentenac A. 1995. A universally conserved region of the largest subunit participates in the active site of RNA polymerase III. EMBO J. 14, 3766-3776.
5. Cramer P., Bushnell D.A., Kornberg R.D. 2001. Structural basis of transcription: RNA polymerase II at 2.8 Å resolution. Science. 292, 1863-1876.
6. Vassylyev D.G., Sekine S., Laptenko O., Lee J., Vassylyeva M.N., Borukhov S., Yokoyama S. 2002. Crystal structure of a bacterial RNA polymerase holoenzyme at 2.6 Å resolution. Nature. 417, 712-719.
7. Zhang G., Campbell E.A., Minakhin L., Richter C., Severinov K., Darst S.A. 1999. Crystal structure of Thermus aquaticus core RNA polymerase at 3.3 Å resolution. Cell. 98, 811-824.
8. Temiakov D., Zenkin N., Vassylyeva M.N., Perederina A., Tahirov T.H., Kashkina E., Savkina M., Zorov S., Nikiforov V., Igarashi N., Matsugaki N., Wakatsuki S., Severinov K., Vassylyev D.G. 2005. Structural basis of transcription inhibition by antibiotic streptolydigin. Mol. Cell. 19, 655-666.
9. Sosunov V., Zorov S., Sosunova E., Nikolaev A., Zakeyeva I., Bass I., Goldfarb A., Nikiforov V., Severinov K., Mustaev A. 2005. The involvement of the aspartate triad of the active center in all catalytic activities of multisubunit RNA polymerase. Nucleic Acids Res. 33, 4202-4211.
10. Fish R.N., Kane C.M. 2002. Promoting elongation with transcript cleavage stimulatory factors. Biochim. Biophys. Acta. 1577, 287-307.
11. Wehrli W., Knusel F., Schmid K., Staehelin M. 1968. Interaction of rifamycin with bacterial RNA polymerase. Proc. Natl. Acad. Sci. USA. 61, 667-673.
12. Campbell E.A., Korzheva N., Mustaev A., Murakami K., Nair S., Goldfarb A., Darst S.A. 2001. Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell. 104, 901-912.
13. Mosteller R.D., Yanofsky C. 1970. Transcription of the tryptophan operon in Escherichia coli: Rifampicin as an inhibitor of initiation. J. Mol. Biol. 48, 525-531.
14. Hinkle D.C., Mangel W.F., Chamberlin M.J. 1972. Studies of the binding of Escherichia coli RNA polymerase to DNA: 4. The effect of rifampicin on binding and on RNA chain initiation. J. Mol. Biol. 70, 209-220.
15. McClure W.R., Cech C.L. 1978. On the mechanism of rifampicin inhibition of RNA synthesis. J. Biol. Chem. 253, 8949-8956.
16. Jin D.J., Gross C.A. 1988. Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance. J. Mol. Biol. 202, 45-58.
17. Severinov K., Soushko M., Goldfarb A., Nikiforov V. 1993. Rifampicin region revisited. New rifampicinresistant and streptolydigin-resistant mutants in the β subunit of Escherichia coli RNA polymerase. J. Biol. Chem. 268, 14,820-14,825.
18. Lisitsyn N.A., Sverdlov E.D., Moiseyeva E.P., Danilevskaya O.N., Nikiforov V.G. 1984. Mutation to rifampicin resistance at the beginning of the RNA polymerase beta subunit gene in Escherichia coli. Mol. Gen. Genet. 196, 173-174.
19. Severinov K., Soushko M., Goldfarb A., Nikiforov V. 1994 R ifR mutations in the beginning of the Escherichia coli rpoB gene. Mol. Gen. Genet. 244, 120-126.
20. Naryshkina T., Mustaev A., Darst S.A., Severinov K. 2001. The β′ subunit of Escherichia coli RNA polymerase is not required for interaction with initiating nucleotide but is necessary for interaction with rifampicin. J. Biol. Chem. 276, 13,308-13,368.
21. Wichelhaus T., Schafer V., Brade V., Boddinghaus B. 2001. Differential effect of rpoB mutations on antibacterial activities of rifampicin and KRM-1648 against Staphylococcus aureus. J. Antimicrob. Chemother. 47, 153-156.
22. Williams D.L., Spring L., Collins L., Miller L.P., Heifets L.B., Gangadharam P.R., Gillis T.P. 1998. Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 42, 1853-1857.
23. Artsimovitch I., Vassylyeva M.N., Svetlov D., Svetlov V., Perederina A., Igarashi N., Matsugaki N., Wakatsuki S., Tahirov T.H., Vassylyev D.G. 2005. Allosteric modulation of the RNA polymerase catalytic reaction is an essential component of transcription control by rifamycins. Cell. 122, 351-363.
24. Irschik H., Jansen R., Gerth K., Hofle G., Reichenbach H. 1985. The sorangicins, novel and powerful inhibitors of eubacterial RNA polymerase isolated from myxobacteria. J. Antibiotics. 40, 7-13.
25. Rommele G., Wirz G., Solf R., Vosbeck K., Gruner J., Wehrli W. 1990. Resistance of Escherichia coli to rifampicin and sorangicin A: A comparision. J. Antibiot. 43, 88-91.
26. Campbell E.A., Pavlova O., Zenkin N., Leon F., Irschik H., Jansen R., Severinov K., Darst S.A. 2005. Structural, functional, and genetic analysis of sorangicin inhibition of bacterial RNA polymerase. EMBO J. 24, 674-682.
27. Mathews D.E., Durbin R.D. 1990. Tagetitoxin inhibits RNA synthesis directed by RNA polymerases from chloroplasts and Escherichia coli. J. Biol. Chem. 265, 493-498.
28. Mathews D.E., Durbin R.D. 1994. Mechanistic aspects of tagetitoxin inhibition of RNA polymerase from Escherichia coli. Biochemistry. 33, 11,987-11,992.
29. Vassylyev D.G., Svetlov V., Vassylyeva M.N., Perederina A., Igarashi N., Matsugaki N., Wakatsuki S., Artsimovitch I. 2005. Structural basis for transcription inhibition by tagetitoxin. Nature Struct. Mol. Biol. 12, 1086-1093.
30. Artsimovitch I., Patlan V., Sekine S., Vassylyeva M.N., Hosaka T., Ochi K., Yokoyama S., Vassylyev D.G. 2004. Structural basis for transcription regulation by alarmone ppGpp. Cell. 117, 299-310.
31. Siddhikol C., Erbstoeszer J.W., Weisblum B. 1969. Mode of action of streptolydigin. J. Bacteriol. 99, 151-155.
32. Schleif R. 1969. Isolation and characterization of streptolydigin resistant RNA polymerase. Nature. 223, 1068-1069.
33. O'Niell A., Oliva B., Storey C., Hoyle A., Fishwick C., Chopra I. 2000. RNA polymerase inhibitors with activity against rifampin-resistant mutants of Staphylococcus aureus. Antimicrob. Agents Chemotherapy. 44, 3163-3166.
34. Heisler L.M., Suzuki H., Landick R., Gross C.A. 1993. Four contiguous aminoacids define the target for streptolydigin resistance in the beta subunit of Escherichia coli RNA polymerase. J. Biol. Chem. 268, 25,369-25,375.
35. Sollner-Webb B., Tower J. 1986. Transcription of cloned eukaryotic ribosomal RNA genes. Annu. Rev. Biochem. 55, 801-830.
36. Lindell T.J., Weinberg F., Morris P.W., Roeder R.G., Rutter W.J. 1970. Specific inhibition of nuclear RNA polymerase II by alpha-amanitin. Science. 170, 447-449.
37. Tuske S., Sarafianos S.G., Wang X., Hudson B., Sineva E., Mukhopadhyay J., Birktoft J.J., Leroy O., Ismail S., Clark A.D. Jr, Dharia C., Napoli A., Laptenko O., Lee J., Borukhov S., Ebright R.H., Arnold E. 2005. Inhibition of bacterial RNA polymerase by streptolydigin: Stabilization of a straight-bridge-helix active-center conformation. Cell. 122, 541-552.
38. Kaushik N., Rege N., Yadav P.N., Sarafianos S.G., Modak M.J., Pandey V.N. 1996. Biochemical analysis of catalytically crucial aspartate mutants of human immunodeficiency virus type 1 reverse transcriptase. Biochemistry. 35, 11,536-11,546.
39. Polesky A.H., Dahlberg M.E., Benkovic S.J., Grindley N.D., Joyce C.M. 1992. Side chains involved in catalysis of the polymerase reaction of DNA polymerase I from Escherichia coli. J. Biol. Chem. 267, 8417-8428.
40. Sonenshein A., Alexander H., Rothstein D., Fisher S. 1977. Lipiarmycin-resistant ribonucleic acid polymerase mutants of Bacillus subtilis. J. Bacteriol. 132, 73-79.
41. Sonenshein A.L., Alexander H.B. 1979. Initiation of transcription in vitro is inhibited by lipiarmycin. J. Mol. Biol. 127, 55-72.
42. Gualtieri M., Guillot P.V., Latouche J., Leonetti J.P. 2006. Mutation in the Bacillus subtilis RNA polymerase β′ subunit confers resistance to lipiarmycin. Antimicrob. Agents Chemotheapy. 50, 401-402.
43. Murakami K., Masuda S., Campbell E., Muzzin O., Darst S. 2002. Structural basis of transcription initiation: An RNA polymerase holoenzyme-DNA complex. Science. 296, 1285-1290.
44. Artsimovitch I., Chu C., Lynch A.S., Landick R. 2003. A new class of bacterial RNA polymerase inhibitor affects nucleotide addition. Science. 302, 650-654.
45. Rusconi A., Calendi E. 1966. Action of daunomycin on nucleic acid metabolism in HeLa cells. Biochim. Biophys. Acta. 119, 413-585.
46. Kriebardis T., Meng D., Aktipis S. 1987. Inhibition of the RNA polymerase-catalyzed synthesis of RNA by daunomycin. Effect of the inhibitor on the late steps of RNA chain initiation. J. Biol. Chem. 262, 12,632-12,640.
47. Kriebardis T., Aktipis S. 1988. Inhibition of the RNA polymerase-catalyzed synthesis of RNA by marcellomycin. Preferential interference of the inhibitor with the stabilization of the ternary promoter-RNA polymerase-nascent RNA complex. J. Biol. Chem. 263, 6960-6963.
48. Delgado M.A., Rintoul M.R., Farias R.N., Salomon R.A. 2001. Escherichia coli RNA polymerase is the target of the cyclopeptide antibiotic microcin J25. J. Bacteriol. 183, 4543-4550.
49. Wilson K.A., Kalkum M., Ottesen J., Yuzenkova J., Chait B.T., Landick R., Muir T., Severinov K., Darst S.A. 2003. Structure of microcin J25, a peptide inhibitor of bacterial RNA polymerase, is a lassoed tail. J. Am. Chem. Soc. 125, 12,475-12,483.
50. Yuzenkova J., Delgado M., Nechaev S., Savalia D., Epshtein V., Artsimovitch I., Mooney R.A., Landick R., Farias R.N., Salomon R., Severinov K. 2002. Mutations of bacterial RNA polymerase leading to resistance to microcin J25. J. Biol. Chem. 277, 50,867-50,875.
51. Adelman K., Yuzenkova J., La Porta A., Zenkin N., Lee J., Lis J.T., Borukhov S., Wang M.D., Severinov K. 2004. Molecular mechanism of transcription inhibition by peptide antibiotic Microcin J25. Mol. Cell. 14, 753-762.
52. Semenova E., Minakhin L., Bogdanova E., Nagornykh M., Vasilov A., Heyduk T., Solonin A., Zakharova M., Severinov K. 2005. Transcription regulation of the EcoRV restriction-modification system. Nucleic Acids Res. 33, 6942-6951.